Gerresheimer stock rises 1.20 percent as Q2 EBITDA recovers

Published on 10/07/2026 at 13:19 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Gerresheimer stock was trading at EUR 28.72 on October 7, 2026, after Q2 adjusted EBITDA rose to EUR 102 million. Revenue reached EUR 578 million, while 2026 guidance stayed unchanged.

Editorialfoto eines Trading-Floors mit MDAX- und Xetra-Kurstafeln — Gerresheimer AG, ISIN DE000A0LD6E6, notiert im MDAX an der Frankfurter Börse Xetra, Trading-Floor-Editorialbild, Illustration mit AI erstellt.

Gerresheimer stock was trading at EUR 28.72 on Xetra on October 7, 2026, up 1.20 percent from the prior close. The latest operating update showed adjusted EBITDA rising 52.2 percent sequentially to EUR 102 million in Q2 2026, giving the pharmaceutical packaging group a measurable recovery point.

Q2 EBITDA rebounds sharply

According to Financial Times on September 30, 2026, Q2 revenue reached EUR 578 million, up EUR 55 million from Q1 2026 but down from EUR 614 million in Q2 2025. Adjusted EBITDA increased from EUR 67 million in Q1 to EUR 102 million, although it remained below EUR 126 million in the prior-year quarter.

The improvement was visible in the margin as well. Adjusted EBITDA margin reached 17.6 percent in Q2 2026, while first-half adjusted EBITDA totaled EUR 168 million against EUR 224 million in the first half of 2025, according to Financial Times.

Guidance depends on execution

Gerresheimer said on September 30, 2026, that it expects a stronger second half of 2026. The company kept organic revenue guidance in the lower half of the EUR 2.3 billion to EUR 2.4 billion range, with an adjusted EBITDA margin target of 17 percent to 18 percent and free cash flow before M&A of negative EUR 50 million to negative EUR 100 million.

Cash generation remains the counter-factor. Investing.com reported that free cash flow before M&A was negative EUR 92 million in Q2 2026, while net financial debt stood at EUR 2,058 million at the quarter end.

Stock trades below yearly high

At EUR 28.72 on October 7, 2026, the stock remained EUR 8.96 below its 52-week high of EUR 37.68 and EUR 13.89 above its 52-week low of EUR 14.83. The current market capitalization was EUR 992.0 million, with 14,082 shares traded at the quoted time.

Gerresheimer stock was last at EUR 28.72 on Xetra on October 7, 2026 at 1:00 p.m. CEST. The next valuation test is whether the second-half recovery can translate into the reaffirmed margin and cash-flow targets.